We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current SRZNW market cap is 553.41k. The company's latest EPS is USD -1.4078 and P/E is -6.76.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 10M |
| Operating Income | -11.19M | -9.72M | -9.13M | -9.05M | 1.23M |
| Net Income | -10.45M | -8.91M | -8.83M | -25.26M | -1.43M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 12.5M | 0 |
| Operating Income | -546k | -54.39M | -44.34M | -45.78M |
| Net Income | -2.12M | -54.65M | -36M | -43.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 53.97M | 46.08M | 36.72M | 45.07M | 48M |
| Total Liabilities | 8.44M | 8.15M | 6.58M | 39.01M | 42.33M |
| Total Equity | 45.53M | 37.94M | 30.14M | 6.06M | 5.67M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 93.78M | 137.17M | 89.44M | 46.08M |
| Total Liabilities | 6.91M | 27.47M | 13.43M | 8.15M |
| Total Equity | 5M | 109.7M | 76M | 37.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -33.05M | -40.36M | -8.75M | -14.36M | -21.11M |
| Investing | 42.22M | 51.72M | -7k | -7k | -7k |
| Financing | 135k | 276k | N/A | 16.09M | 16.09M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -934k | -48.81M | -44.15M | -40.36M |
| Investing | -92M | -77.71M | 38.31M | 51.72M |
| Financing | 93.92M | 124.63M | -2.57M | 276k |
| Market Cap | 553.41k |
| Price to Earnings Ratio | -6.76 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 8.08 |
| Price to Book Ratio | 7.67 |
| Dividend Yield | - |
| Shares Outstanding | 30.58M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.01 (56.22%) |
| Company Name | Surrozen Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.surrozen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
